title: Letter: stool adalimumab detection in ulcerative colitis and Crohn's disease--authors' reply.
authors.affiliation: Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. michael.rosen@cchmc.org.|Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA. michael.rosen@cchmc.org.
authors.forename: M J
authors.initials: MJ
authors.lastname: Rosen
authors.affiliation: Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.|Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
authors.forename: P
authors.initials: P
authors.lastname: Minar
authors.affiliation: Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.|Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
authors.forename: A A
authors.initials: AA
authors.lastname: Vinks
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D006801:Humans; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha